Sinopharm Group Co., Ltd.

1099
Failed

Company Overview

The company is a core enterprise belonging to China Pharmaceutical Group Co., Ltd., founded in January 2003 and listed on the Hong Kong Stock Exchange in September 2009 (stock code: 01099.HK). It is the largest wholesaler and retailer of pharmaceuticals, medical devices and healthcare products in China, as well as a leading supply chain service provider. The Group is mainly engaged in the distribution business of pharmaceuticals and medical devices. Relying on a nationwide distribution and distribution network, it provides comprehensive distribution, distribution and other value-added services to domestic and foreign manufacturers and suppliers of pharmaceuticals, medical devices, consumables and other healthcare products, as well as downstream hospitals, other distributors, retail pharmacies, primary care institutions, etc. At the same time, the Group manages the retail pharmacy chain network through direct operation and franchising in major cities in China, sells pharmaceuticals and health products to end consumers, and is now in a leading position in the Chinese pharmaceutical retail industry. In addition, the Group is also engaged in the manufacture and sale of pharmaceuticals, chemical preparations and laboratory supplies, and actively innovates in health-related industries such as pharmaceuticals and medical care, and explores the collaborative development of diversified businesses. Relying on the established scale advantage, customer resources, network platform and brand position, the Group will make full use of the steady growth market environment of China's pharmaceutical and healthcare industry, seize opportunities for medical system reform, further consolidate and enhance its leading position in the market, continue to forge ahead, and strive to become an efficient pharmaceutical supply chain organizer and comprehensive service solution provider for the industry.

Country
HK
Market Cap
$8.18B
Last Fiscal Year
2023
Final Shariah Status
Failed
Compliance Analysis Overview

Shariah Compliance Benchmarks:

  • Business Compliance: Non-Shariah compliant revenue must be less than 5% of total revenue
  • Liabilities Compliance: Interest-bearing debt must be less than 33% of market capitalization
Business Compliance
0.18% passed
5% Threshold
0.2%
Liabilities Compliance
117.39% failed
33% Threshold
117.4%
Final Shariah Status
Failed

This stock does not meet all Shariah compliance criteria according to AAOIFI standards.

Stock Information
Name Sinopharm Group Co., Ltd.
Ticker 1099
Main Business Medical Distribution
Type Common Stock
Industry Medical Distribution
Country HK
Market Cap $8.18 B

Shariah Analysis Breakdown

Business compliance Breakdown
Revenue Segment Value ($M) Non-Compliant ($M) Reason
Pharmaceutical distribution $216,550.0 $0.0 -
Medical device business $62,650.0 $0.0 -
Pharmaceutical retail business $17,360.0 $0.0 -
Other business $4,390.0 $0.0 -
Interest income $542.8 $542.8 -
Total $301,492.8 $542.8 0.18% (passed)
Liabilities Compliance Breakdown
Liability Item Value ($M) % of Market Cap
bank loans and overdrafts $7,665,266,106.4 93.71%
long term bank loan $1,936,974,789.9 23.68%
Total Interest-Bearing Debt $9,602,240,896.4 117.39%
Market Capitalization $8,180,000,000.0 100.00%
Compliance Status Threshold: 33% failed